Riskpilot← Back to searchSign inGet full accessRxEye AB
ABDissolvedOrg 5568079924Economic activity was not specified by tax authority · NACE 0000Est. 20100 employees
Revenue 2021
SEK 0
EBITDA margin
—
0% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK -7K
0% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -7K | +0% |
| Net profit | SEK -7K | +0% |
| Total assets | SEK 40,6M | +0% |
| Equity | SEK 40,6M | +0% |
| Employees | 0 | — |
Legal name
RxEye AB
Org number
5568079924
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
8 maj 2010
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-04-30
Financial year
January – December
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva och utveckla en marknadsplats för bilddiagnostik och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −77 | −19 | — | −7 | −7 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −77 | −19 | 0 | −7 | −7 |
| Net financials | 6 | −2 | — | — | — |
| Profit before tax | 40 441 | −21 | 0 | −7 | −7 |
| Tax | −8 896 | −0 | −0 | −0 | −0 |
| Net profit | 31 545 | −21 | 0 | −7 | −7 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 41 266 | 40 574 | 40 595 | 40 588 | 40 581 |
| Equity | 40 595 | 40 574 | 40 595 | 40 588 | 40 581 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 671 | 0 | 0 | 0 | 0 |
| Total debt | 671 | — | — | — | — |
EBITDA margin
-700000.0%
This company
15.8%
Market median
-4430480% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20172021
Net profit margin
-700000.0%
This company
8.1%
Market median
-8642075% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AB Chief Auditor | Chief Auditor | 2022 – 2022 |
MU Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RxEye AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Bo Henrik Troberg | Chief Auditor | 0 companies |
| Mia Ulrika Rutenius | Chief Auditor | 0 companies |
| Mats Börje Folke Franzén | Board of Directors | 0 companies |
| Clas Harald Torbjörn Kronander | Chairman | 0 companies |
| Lars Erik Staffan Bergström | Deputy Board Member | 0 companies |